Identification of a Novel SCN5A gene variant in a young female with atrioventricular canal defect in the absence of classical Brugada syndrome phenotype

Main Article Content

Ritwick Mondal Rahul Manna Emili Banerjee Julián Benito-León Shramana Deb

Abstract

Background: Brugada syndrome is generally considered a cardiac channelopathy disorder characterized by syncope or sudden cardiac death. The sodium voltage-gated channel alpha subunit 5 (SCN5A) gene is the most commonly mutated gene associated with Brugada syndrome. Recent discoveries of new variants of this gene, along with current guidance of family screening, have identified several asymptomatic carriers with potentially causative mutations.


Case presentation: We present the case of a 25-year-old female patient without any family history of Brugada syndrome nor related congenital cardiovascular disorders, with an extensive atrioventricular canal defect, who tested positive for a novel heterozygous variant NM_198056.3: c.3169G>C (p. Asp1057 His) in the SCN5A gene. She had no history of syncope or aborted sudden cardiac death except for recurrent chest infections since her early childhood. Intriguingly, she did not show a type I Brugada electrocardiogram pattern.


Conclusions: This report provides a novel heterozygous variant NM_198056.3: c.3169G>C (p. Asp1057 His) in the SCN5A gene, which may have a potential detrimental effect.

Keywords: Brugada syndrome, atrioventricular canal, atrial fibrillation, novel variant, whole genome sequencing, Sanger sequencing.

Article Details

How to Cite
MONDAL, Ritwick et al. Identification of a Novel SCN5A gene variant in a young female with atrioventricular canal defect in the absence of classical Brugada syndrome phenotype. Medical Research Archives, [S.l.], v. 12, n. 7, july 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5527>. Date accessed: 15 nov. 2024. doi: https://doi.org/10.18103/mra.v12i7.5527.
Section
Research Articles

References

1. Mizusawa Y, Wilde AA. Brugada syndrome. Circ Arrhythm Electrophysiol. 2012;5(3):606-616. doi:10.1161/CIRCEP.111.964577.

2. Eckardt L, Veltmann C. More than 30 years of Brugada syndrome: a critical appraisal of achievements and open issues. 30 Jahre Brugada-Syndrom – eine kritische Bewertung und Diskussion offener Fragen. Herzschrittmacherther Elektrophysiol. 2024;35(1):9-18. doi:10.1007/s00399-023-00983-y.

3. George AL Jr, Varkony TA, Drabkin HA, et al. Assignment of the human heart tetrodotoxin-resistant voltage-gated Na+ channel alpha-subunit gene (SCN5A) to band 3p21. Cytogenet Cell Genet. 1995;68(1-2):67-70. doi:10.1159/000133892.

4. Kapplinger JD, Tester DJ, Alders M, et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010;7(1):33-46. doi:10.1016/j.hrthm.2009.09.069.

5. Li W, Yin L, Shen C, Hu K, Ge J, Sun A. SCN5A variants: association with cardiac disorders. Front Physiol. 2018;9:1372. Published 2018 Oct 9. doi:10.3389/fphys.2018.01372.

6. Cerrone M, Costa S, Delmar M. The genetics of Brugada syndrome. Annu Rev Genomics Hum Genet. 2022;23:255-274. doi:10.1146/annurev-genom-112921-011200.

7. Moras E, Gandhi K, Narasimhan B, et al. Genetic and molecular mechanisms in Brugada syndrome. Cells. 2023;12(13):1791. Published 2023 Jul 5. doi:10.3390/cells12131791.

8. Aronsen JM, Swift F, Sejersted OM. Cardiac sodium transport and excitation-contraction coupling. J Mol Cell Cardiol. 2013;61:11-19. doi:10.1016/j.yjmcc.2013.06.003.

9. https://sift.bii.a-star.edu.sg/

10. [CFSSP Server – biox.ml/cf].

11. Anoosha P, Sakthivel R, Gromiha MM. Prediction of protein disorder on amino acid substitutions. Anal Biochem. 2015;491:18-22. doi:10.1016/j.ab.2015.08.028.

12. Wilde AA, Antzelevitch C, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J. 2002;23(21):1648-1654. doi:10.1053/euhj.2002.3382.

13. Gillette PC. Genetic and environmental risk factors of major cardiovascular malformations: The Baltimore-Washington infant study: 1981-1989. Ferencz C, Correa-Villasenor A, Loffredo CA, Wilson PD, eds. Armonk, NY: Futura Publishing Company Inc; 1998. 463 pages. Clin Cardiol. 2009;21(11):867-868. Published 2009 Feb 3. doi:10.1002/clc.4960211122. PMCID: PMC6656173.

14. Digilio MC, Marino B, Toscano A, Giannotti A, Dallapiccola B. Atrioventricular canal defect without Down syndrome: a heterogeneous malformation. Am J Med Genet. 1999;85(2):140-146.

15. Suzuki K, Sonoda K, Aoki H, et al. Association between deleterious SCN5A variants and ventricular septal defect in young patients with Brugada syndrome. JACC Clin Electrophysiol. 2022;8(3):297-305. doi:10.1016/j.jacep.2022.01.007.